List of Healthcare Companies : pharma, medtech, diagnostics, digital health, biotech, etc.
[table id=19 /]
Biotech Companies : Presentation of some Biotech Companies :
- Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson’s Disease Patients
- Albus Health Device Detects Early Warning Signs of Child Asthma Attacks Up To Five Days Before Onset
- Vaxxas Expands Global Intellectual Property Portfolio for Exclusive Manufacture and Sale of Needle-Free Vaccination Technology
- Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group
- Steritas Announces Collaboration with argenx to Advance Evidence for Novel Steroid-sparing Therapeutics
- Cancer Targeted Technology Receives Fast Track $2.4M Grant to Develop an Innovative PSMA-Targeted Small Molecule Drug Conjugate for Prostate Cancer
- Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024
- Epirium Bio Presented Late-Breaking Preclinical Data of MF-300 (15-PGDH Enzyme Inhibitor) at the Gerontological Society of America Annual Scientific Meeting 2024
- Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024
- Resalis Therapeutics Gains Strategic Equity Investment from Sanofi
- Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis-Focused Pipeline
- Qurient Launches Clinical Trial for Acute Myeloid Leukemia Treatment with Adrixetinib (Q702)
- QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery
- Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
- Immunome to Present Poster Highlighting Preclinical Evaluation of IM-1021, a ROR1-Targeted Antibody Drug Conjugate, at the 36th EORTC-NCI-AACR Symposium
- Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur
- Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder
- invIOs raises €8.2 million in a Series A to finance pipeline progress in immuno-oncology
- Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases
- Pfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial
- MiLaboratories Secures Series A, Raising Total Funding to $10 Million to Revolutionize the World of Genomic Research
- Loci Orthopaedics Closes €12.8 Million Series A Financing
- Bayer announces positive topline results for NUBEQA® (darolutamide) from Phase III trial in men with metastatic hormone-sensitive prostate cancer (mHSPC)
- Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor
- XyloCor and SmartCella enter into license agreement for use of the Extroducer to administer novel gene therapy XC001 to the heart
- Epsilogen announces CTA approval for Phase Ib trial of MOv18 IgE in platinum-resistant ovarian cancer
- Genexine Announces Merger with EPD Biotherapeutics to Strengthen Drug Development Pipeline
- Genentech Provides Update on Phase II/III SKYSCRAPER-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer
- GSK and CureVac to Restructure Collaboration into New Licensing Agreement
- 4Moving Biotech welcomes Luc Boblet as Chief Executive Officer to lead next phase of growth
- Marea Therapeutics Launches with $190 Million to Accelerate a New Generation of Medicines for Cardiometabolic Diseases
- Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy
- Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
- Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
- Agomab Receives FDA Orphan Drug Designation for AGMB-447 in Idiopathic Pulmonary Fibrosis
- Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate
- QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments
- ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody Against the SARS-CoV-2 Variant JN.1
- RS Oncology Announces Positive Data from a Phase 1 Clinical Trial of RSO-021, a First-in-Class Therapeutic for Malignant Pleural Mesothelioma
- Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO
- iCell Gene Therapeutics Announces Positive Clinical Data from Investigator Initiated Phase 1 Trial Evaluating BCMA-CD19 Compound CAR in Patients with Systemic Lupus Erythematosus/Lupus Nephritis Published in Annals of the Rheumatic Diseases
- Sinaptica Therapeutics Selected for StartUp Health’s Alzheimer’s Moonshot
- Cimeio Therapeutics : CD45 ADC and Shielded HSCs Represent a Potentially Universal Therapy for Blood Cancers
- Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company
- AmorChem’s RNA Zipcode Delivery Technology Investment Exits via New York-Based Kodikaz Therapeutic Solutions, Inc.
- Engitix Announces Appointment of Matthew Edwards Ph.D., as SVP Discovery and Emma Huang Ph.D., as VP Data Sciences
- Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases
- Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
- Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design
- Chapter Raises $50 Million Led By XYZ Venture Capital to Help Millions More Seniors Maximize Their Medicare
- NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
- 4M Therapeutics : Novel Preclinical Data Demonstrating Potent Effects of Inhibitors of GSK3β for the Treatment of Bipolar Disorder
- Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure
- Be Biopharma Announces New Preclinical Data for Novel B Cell Medicine for the Potential Treatment of Hypophosphatasia
- EGLE Therapeutics Strengthens its Leadership Team with the Appointment of Pejvack Motlagh, MD, MSc, as Chief Medical Officer and its Board of Directors with Appointment of John Celebi, MBA, as Independent Board Member
- Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
- Seragon Biosciences completes Pre-Clinical Studies of its novel anti-aging candidate SRN-901
- Neurenati Therapeutics Strengthens Its Board of Directors With the Appointment of Dr. Marielle Cohard-Radice
- ENA Respiratory Receives USPTO Notice of Allowance for Key Patent Covering INNA-051, a First-in-Class Antiviral Innate Immunomodulator
- Cagent Vascular appoints Chairman Brian Walsh to expanded role as Chief Executive Officer
- EyeDNA Therapeutics Announces Positive 24-month Data from Ongoing Phase I/II Trial of HORA-PDE6b Gene Therapy in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b
- FDA Approves ColoSense™ – Geneoscopy’s Noninvasive Multi-target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test
- OverT Bio Raises $16 Million, Tapping Innovative Reprogramming of Immune Cells to Deliver Next-Generation Therapies
- Inmagene Reports Positive Interim Results from Phase 2a Trial of IMG-007, a Nondepleting Anti-OX40 Monoclonal Antibody with an Extended Half-life, for the Treatment of Atopic Dermatitis
- TAR-210 results show 90 percent recurrence-free survival and 90 percent complete response in patients with high-risk and intermediate-risk non-muscle-invasive bladder cancer, respectively
- Epredia and NovaScan Announce Intent to Enter U.S. Distribution Agreement for MarginScan™ Device for Non-Melanoma Skin Cancer Detection
- Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
- Nvelop Therapeutics Announces Members of Its Scientific Advisory Board
- Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
- PANCREACTIC CANCER: SUCCESFUL TRIAL AGAINST PANCREATIC CANCER WITH DEFENCE’S ARM-002 ANTI-CANCER VACCINE
- Remepy Launches with $15 Million in Funding To Bring First Hybrid Drug To Market
- SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
- Qlaris Bio Completes $24 Million Series B Financing Round to Advance QLS‑111, a First-in-class IOP-lowering Drug Candidate for Glaucoma
- Newron Pharmaceuticals announces positive top-line results from potentially pivotal Phase II/III study 008A with evenamide in schizophrenia patients
- BosterBio : 30 years designing high affinity antibodies and immunoassays
- Xeno Biosciences Announces New CEO and Financing
- Jacques Banchereau, PhD Appointed as Chief Scientific Officer at Javelin Biotech
- Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
- Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
- Theolytics successfully closes latest financing raising total of £19M ($24.5M) and welcomes Sound Bioventures as new investor
- Medincell Enters Into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies
- Hemostatics, CUN and ICIQ receive €2.5M to validate a revolutionary therapy against disabling and lethal haemorrhage
- KYinno – Boost your drug discovery with innovative products and services
- Ferronova – Nanoparticle Trial Begins in Patients With Gastric and Oesophageal Cancers
- S2 Genomics Announces Groundbreaking Single Cell FFPE Sample Prep Isolation Product
- Merck’s Corporate Venture M Ventures Arm Backs Nucleai to Advance Its First-in-class Spatial AI Biomarker in Active Clinical Enrollment
- Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
- Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors
- Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates
- AriBio Licenses Exclusive Marketing Rights for AR1001 for Alzheimer’s Disease in China for $770 Million USD
- Promising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024
- Italfarmaco Receives FDA Approval for Duvyzat™ (givinostat) in Duchenne Muscular Dystrophy
- Flosonics Medical Secures $20 Million USD in Series C Funding Led by New Leaf Venture Partners to Accelerate Growth
- InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in China
- Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004
- Seismic Therapeutic – Preclinical Data for Novel Immunoglobulin Sculpting Enzyme
- Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
- NurExone Presenting Novel Regulatory Pathways for Exosomes Therapies at Global Summit
- FogPharma Announces $145 Million Financing to Support Ongoing Clinical Development of FOG-001 and Accelerate Helicon Peptide Portfolio
- MaaT Pharma Announces Positive Review from the DSMB on the Ongoing Phase 1 Clinical Trial Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)
- Animal Biosciences Announces New Canine Clinical Research Evaluating Reversal of Age-Related Signs in Dogs
- Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy
- Orbis Medicines Launches with €26 Million Seed Financing to Transform Macrocycle Drug Development through Next-Generation Orally Dosable ‘nCycles’
- Promising Results: TGR-63 Enhances Memory in Alzheimer’s Mouse Model
- VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline
- A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application
- Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited
- Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic Kidney Disease
- MiNA Therapeutics Presents Late-Breaking Positive Phase 1b Data for MTL-CEBPA in Combination with an Anti-PD1 Checkpoint Inhibitor at the Annual American Association of Cancer Research (AACR) Meeting
- Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC
- Alpha Cancer Technologies (ACT) Publishes Pre-Clinical Study Results in Cancer Cell International Demonstrating Excellent Safety and Significant Anti-Tumor Activity from the Company’s Next Generation ADC, ACT-903
- Rallybio Announces Clinical Proof-of-Concept Results for RLYB211, an Anti-HPA-1a Polyclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT), Published in the Journal of Thrombosis and Haemostasis
- Morphogenesis Inc. Acquires TυHURA Biopharma’s First-in-Class Antibody Drug Conjugates (ADCs) Technology Designed to Overcome Acquired Resistance to Cancer Immunotherapy
- Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer
- Top 6 Arizona bioscience startups in 2023
- Tvardi Therapeutics Announces First Patients Dosed in Phase 2 Trial of TTI-101 in Metastatic Breast Cancer
- Junshi Biosciences Announces Toripalimab in Combination with Chemotherapy for Treatment of Advanced Triple-negative Breast Cancer Met Primary Endpoint in Phase 3 Clinical Study
- Ryne Biotechnology Awarded $4 Million from the California Institute for Regenerative Medicine
- U.S. FDA Approves Trodelvy® in Pre-treated HR+/HER2- Metastatic Breast Cancer
- Genoscience Pharma – new approaches disrupting cancer cell lysosomal functions
- ARMGO Pharma – developing small molecule Ryanodine Receptor modulators for treating cardiac, musculoskeletal and neurological disorders
- Nanostics – micro-flow cytometry to quantify extracellular vesicle size, concentration and marker abundance, with advanced machine learning algorithms to determine disease states
- Alpha Cognition – developing novel treatments for neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis
- Cell-Easy – reducing stem cells manufacturing cost for cell therapies
- Glycorex Transplantation – removing antibodies from blood to improve transplantation and fight autoimmune diseases
- Biophytis – therapeutics to slow down the degenerative processes associated with aging
- Sycai Medical – Early stage diagnosis of pancreatic cancer through Medical Imaging and Artificial Intelligence
- Chiron Biotech – Multimaterial Bioprinting
- Accegen Biotech – complete cell & molecular biology products and services
- Cytena – single cells on demand
- Cytoo – next generation HCS with physiologically relevant cellular models
- MJN Neuroserveis – predicting epileptic seizures
- Manetco – Management and New Technologies development and implementation
- 007 Chemicals – chemical building blocks
- EOS Med Chem – Medicinal Chemical manufacturer
- CAPITAL CELL – Life science equity crowdfunding platform
- BATAVIA BIOSCIENCES – Accelerate Biotechnology
- Capital Cell UK launches with value adding partnerships and new investment platform
- BioExpert Network : REVOLUTIONISE SCIENCE WITH YOUR KNOWLEDGE
- Medicortex – Rapid biochemical diagnostics for brain injury
- Celon Pharma had the largest IPO on the Polish capital market in 2016
- Taigen Bioscience – nucleic extraction, PCR amplification and molecular diagnostics
- AgileBio – collaborative tools that enhance research productivity
- Hera BioLabs – implementation of Precision Toxicology
- DDI-Predictor – predict drug drug interactions mediated by cytochromes
- Samplify Bio – DNA Collection Made Simple
- Biomere – preclinical CRO
- Agarose Bead Technologies – separation / purification products derived from agarose
- Sekisui XenoTech Provides Pooled Human Liver Homogenate for Evaluation of Drug Metabolizing Enzymes and Proteins
- Creative Bioarray – Cells and Tissue Arrays
- Biotech Africa – eradicating disease through early and innovative diagnostics
- Biomatik – life sciences and drug discovery
- Aduro Biotech – engineered Immunotherapy for Cancer
- Anton Paar – process measuring systems
- Worthington Biochemical – high quality enzymes
- Newron Pharmaceuticals – innovative therapies for Central Nervous System
- Kromaton – centrifugal partition chromatography
- IDD Biotech – differentiated therapeutic MAbs
- Bavarian Nordic – poxviral-based vaccine
- Merozyne – muscular dystrophy
- Biotage – instruments for analytical, organic and peptide chemistry
- Cebiotex – drug delivery with electrospun nanofiber technology
- Poietis – 4D Bioprinting
- Eyebrain – neurological and psychiatric diseases
- Bioinvent – antibody drug discovery
- Scancell – innovative ImmunoBody
- GNA Biosolutions – ultra-fast laser heating of nanoparticles
- Lucigen – simplifying genomics
- Ubiquitome – ubiquitous cloud connected, genetic analysis devices
- Swecure – immunoregulatory disorders
- Saromics – structure-based drug design
- Biocision – ice-free cooling systems
- Algosource Technologies – photosynthetic microalgae
- Inivata – non-invasive tumour analysis from circulating DNA
- Fluidigm – single-cell analysis
- Maverix Biomics – manage next generation sequencing data
- IntelliCyt – cell and bead-based screening solutions
- Cupid Peptides – cell permeable peptides
- Biognosys – next-generation proteomics
- Biodesix – cancer diagnostics
- Immunxperts – immunogenicity assessment
- YSS enzymes – enzymes, probiotics and antibacterial peptides
- OncoQR – adjustable cancer immunotherapy
- Synthelis – cell-free systems
- Gyros – miniaturized immunoassays
- Immunethep – neonatal vaccine
- LabWorm – social network for scientists
- Mint Labs – neuroimaging in the cloud
- Genome Profiling – epigenetic biomarkers
- BOC Sciences – inhibitors and custom synthesis
- Starna – spectrophotometer, fluorimeter and colourimeter cells
- Alkahest – developing therapies derived from blood
- Swift Biosciences – genomics and personalized medicine
- Cynata – stem cell industry
- BioFunds.org – you can finance research for Free !
- Antabio – next generation of antibacterial drugs
- Lytix Biopharma – oncolytic peptide immunotherapy
- CD Genomics – Whole Genome Sequencing
- Celenys – 3D cell culture
- Novaptech – development of aptamers
- Chemotargets – predicting the target and safety profile of small molecules
- Oncurious – treating Medulloblastoma
- Imabiotech – evaluation of drug efficacy and toxicity
- Primary Peptides – peptide-mediated protein knockdown
- Bioagilytix – bioanalytical CRO for your large-molecule needs
- Exosome Diagnostics – biofluid-based diagnostics
- Hamilton Storage Technologies : the Verso Platform for Sample Management
- Azure Biosystems cSeries Imaging Systems
- Crownbio – cancer Immunotherapy and xenograft models
- InSphero – organotypic 3D cell culture models
- Click4tag – detecting pathogenic bacteria
- Labcyte – revolutionizing Liquid Handling
- Anaxomics – systems biology solutions
- Herolab – universal benchtop centrifuges
- Vivantis Technologies – restriction enzymes and DNA amplification
- Gel Company – gel documentation systems
- Eikonix – imaging systems
- Promab – custom rabbit monoclonal antibody
- Cristal Therapeutics – next generation nanomedicines
- PX Biosolutions – innovative vaccine adjuvant platform
- GEG-tech – vectorization systems
- PharmaCell – cell therapy and regenerative medicine CMO
- Histalim – in situ hybridization and histology
- CiMaas – cellular immonotherapy
- Actual Analytics – behavioral neuroscience
- PEP Therapy – innovative peptides as targeted therapies for oncology
- SkylineDx – innovative signature-based diagnostic tests
- NanoEntek – live cell imaging systems
- Mobio – RNA purification and isolation method
- Lophius Biosciences – early diagnosis and immunomonitoring
- Amarna – next-generation viral vector platform
- Microgaia Biotech – development of functional bioproducts
- InDevR – accelerate vaccine characterization and production
- Bioo Scientific – increasing sensitivity, flexibility and speed of NGS
- Creative Biolabs – bovine antibodies with Ultralong CDR3s
- Neurosys – drug discovery for neurodegenerative diseases
- Keyence – microscopes and sensors
- Mind the Byte – SaaS for Drug Discovery
- Mitotech – mitochondrially addressed antioxidants
- Intercept Pharma – bile acid therapeutics
- Abbiotec – protein transfection reagent
- Cellular Research – high-resolution investigation of single cells
- Denator – stabilizing the proteome
- Ocata therapeutics – regenerative ophthalmology
- Probiogen – intelligent biopharma solutions
- Arbor Assays – enzyme activity kits
- Chromotek – single domain camel antibodies
- Smaltis – bacteriology and molecular biology
- Cellecta – functional screening and drug target discovery
- Innate Pharma – therapeutic antibodies
- Oncodesign – preclinical evaluation of anticancer therapies
- Bionano Genomics – high-resolution single-molecule imaging to explore the genome
- Trilink – highly modified oligos
- Protea – bioanalytics
- Denovix – high quality Spectrophotometers and Fluorometers
- Biomay – recombinant allergens
- Aptagen – aptamer-beacon
- Invectys – therapeutic cancer vaccine
- CLC Bio – sequence analysis software
- 3Pbio – cell therapy products
- Poxel – diabetes drug development
- Cytena – single cell separation
- Eligo Bioscience – eligobiotics
- Euformatics – NGS quality management system
- Biocartis – molecular diagnostics solutions
- Abnova – innovation through integrated solutions
- Kite Pharma – engineered Autologous Cell Therapy
- Abraxis – immunochemistry products
- Transgenomic – genetic biomarker identification
- Epitogenesis – vaccine delivery technologies
- Boster – picoband antibodies
- Axerion Therapeutics – prion proteins
- Juno Therapeutics – next generation CAR technology
- DNAtrek – DNA barcode
- Bellicum – dendritic cell vaccines
- XenoTech – drug metabolism studies
- Transposagen – piggyBac Transposon System
- Wyatt Technology – macromolecular characterization
- Cellaria – tumor microenvironment
- c-Lecta – customized enzymes and microbial production strains
- Sangamo – zinc finger proteins therapeutics
- CMDBioscience – computational peptide discovery
- Biomedica – immunoassays
- Mymetics – virosomes based vaccines
- Organovo – 3D bioprinting
- Caribou Biosciences – engineering any genome
- Nabriva Therapeutics – pleuromutilins against multi-drug resistant pathogens
- Isarna Therapeutics – selective TGF-β inhibitors
- Lucigen – isothermal nucleic acid amplification
- TissueGnostics – quantitative analysis of tissue images
- AmplyCell – optimizing monoclonal antibody production
- CRISPR Therapeutics – CRISPR-Cas9 genome-editing
- ProteoGenix – services in molecular biology and immunology
- Agendia – decoding cancer
- Lentikat – Biocatalyst: encapsulation of enzymes or microorganisms
- Mobidiag – molecular diagnostics
- HIV-Therapeutics – HTI immunogen as therapeutic vaccine curing HIV infections
- Ysios Capital – private equity for biotech and biopharma companies
- Epigentek – epigenetic products and services
- Schrodinger – advanced molecular simulations
- Dezima Pharma – anti-dyslipidemic compounds
- Nerviano – antibody drug conjugate
- Applikon Biotechnology – advanced bioreactor systems
- AM-Pharma – recombinant human Alkaline Phosphatase
- ProFibrix – fibrinogen technology
- Taconic Biosciences – research model provider
- PamGene – activity-based kinase and nuclear receptor assays
- Calypso Biotech – auto-immune diseases
- Synaptic Systems – antibodies for neuroscience and cell biology
- Second Genome – microbiome modulators
- ExpreS2ion Biotechnologies – production in Drosophila S2 cells
- ToolGen – genome engineering
- Vectalys – lentiviral vectors
- Biolie – enzymatic extraction
- Abiocode – vPair antibodies
- Motif Bio – antibiotics against multi-drug resistant bacteria
- Merus Labs – targeting underdeveloped biopharma assets
- Sygnis – innovative polymerases
- Cellin Technologies – cell therapy products
- Cellectis – gene-editing
- Hemarina – marine oxygen carriers
- Artes Biotechnology – expression platform
- Sarstedt – automated production processes
- Streck – cell stabilization
- Advanced Analytical – high-throughput nucleic acid analysis systems
- Biotek – microplate instrumentation and software
- TwistDx – isothermal DNA and RNA amplification technology
- Prior Scientific – microscope automation
- Gene Codes – bioinformatics solutions for DNA sequence analysis
- Medigene – personalized immunotherapies
- Selvita – accelerating drug discovery
- ProSci – affinity-purified polyclonal antibodies
- AMSBIO – tissue products
- Mimetas – organ-on-a-chip
- RayBiotech – antibody arrays
- XstalBio – bioformulation
- IDEXX BioResearch – diagnostic services
- Haplogen – haploid genetics tools
- PromoCell – cell culture experts
- OncoDNA – deep sequencing of tumor DNA
- Biogenes – host cell protein assay development
- Horizon Technology – automated sample preparation systems
- Barentzymes – enzyme based solutions
- Adaptimmune – engineered, increased affinity T cell receptors
- Genaxxon – molecular biology products
- TxCell – antigen-specific Type 1 Treg cells
- Polygene – transgenic animal model development
- Sirion Biotech – viral vector platforms
- CEVEC – human cells for human pharmaceuticals
- NZYTech – carbohydrate-active enzymes
- Regeneus – stem cell therapy
- Xcelris Genomics – nucleic acid purification kits
- Austrianova Biotechnology – bioinert polymer encapsulation
- Antisense Therapeutics – antisense drugs
- Novateinbio – endotoxin removal reagents
- VTU Technology – Pichia pastoris protein expression service
- Plasmid Factory – minicircle DNA
- Abgent – monoclonal antibody service
- Arthus Biosystems – S-adenosylmethionine and S-adenosylhomocysteine
- Immunodiagnostic systems – Vitamin D determination
- Syngene – gel imaging and analysis systems
- Ayoxxa – innovative platform for protein multiplexing
- One World Lab – antibody validation
- Premier Biosoft – innovative software in life sciences
- Exbio – hybridoma cell lines
- Cancer Research Technology – cancer research innovations
- Biorbyt – custom peptide synthesis
- Zenith Epigenetics – bromodomain inhibitors
- Somalogic – proteomics tools
- TIB MolBiol – custom synthesis of oligonucleotides
- Smartox – venom peptides
- Vector Laboratories – labeling and detection solutions
- Roslin Cells – pluripotent stem cells
- F2G – antifungal R&D
- Lumora – innovative molecular diagnostics
- Horizon Discovery – genetically-defined cell lines
- Sicgen – polyclonal antibodies
- CoolLED – LED illumination for fluorescence microscopy
- BioMarin – therapies for rare genetic diseases
- Valneva – innovative vaccines against infectious diseases
- Fios Genomics – bioinformatics data analysis services
- ForteBio – analytical systems for biomolecular interactions
- CS Bio – peptide synthesizers
- Affymetrix – genomic analysis
- Integrated DNA Technologies – custom oligonucleotides
- BMG Labtech – microplate readers
- InvivoGen – innate immunology specialists
- Mirus Bio – the Transfection Experts
- Zymo Research – genome-wide epigenetic analyses
- Scienon – assay miniaturization
- PolyActiva – drug-polymer conjugates
- Oxyrane – enzyme replacement therapies
- Immunovaccine – cancer immunotherapies
- Oxford Gene Technology – genetics solutions
- Asterand – human tissue and biofluids
- Origene – your Gene company
- Kytogenics – chitosan derived technology
- Active Motif – epigenetic research
- Biomanda – Next-Gen sequencing and biodiversity
- Gentronix – genotoxicity assays
- BigDNA – innovative cancer therapies
- AllCells – primary human cells
- GenCell – composite liquid cell
- Diagenode – epigenetics solutions
- Clontech – cloning tools
- Generex – drug delivery systems
- GenoSensor – gene profiling and screening
- Sistemic – drug repositioning
- F-star – bispecific antibody
- DiscoveRx – cell-based assays
- Genetic Signatures – molecular diagnostics
- SwitchGear Genomics – genomic regulation
- Ribomed – biomarker detection
- SeqWright – next generation genomics
- Covaris – sample preparation by focused-ultrasonication
- CH3 BioSystems – methyl marks discovery
- eTherapeutics – in-silico drug discovery
- Biogenex – cell and tissue staining
- ChemoMetec – high-speed cell counting
- Viralytics – oncolytic immunotherapies
- eBioscience – immunology reagents
- Axela – multiplex immunoassays
- Panagene – PNA technologies
- ProSpec – bacterial-derived recombinant proteins
- NuGen – genomic sample preparation
- Apexigen – rabbit-derived humanized monoclonal antibodies
- GeneTalk – expert knowledge portal for human sequence variants
- Talisman Therapeutics – Alzheimer’s Stem Cell Model
- Benitec – gene silencing by ddRNAi
- Protein Simple – powering protein research
- 3D Matrix – synthetic extracellular matrix
- Kapa Biosystems – enzyme solutions
- ActivX – in situ kinase profiling
- Biogazelle – transcriptome sequencing services
- HyTest – antibody development for cardiac markers
- Biocrates – metabolic phenotyping solutions
- AROS Applied Biotechnology – total genomic solutions
- AptSci – aptamer solutions
- ReadyCell – easing your screening
- DLVR Therapeutics – nanoparticle drug delivery system
- Riken Genesis – SNP genotyping
- Biocon – delivering affordable innovation
- Immunocore – T cell receptor-based drugs
- Synexa Life Sciences – biomarker expertise
- Nanolive – 3D Cell-Explorer
- Axiogenesis – in vitro models of healthy and diseased cell types and tissue
- Ascletis – RNAi Therapeutic
- Innate Immunotherapeutics – immunomodulator microparticles
- DNAStar – innovative and easy to use software for scientists
- iProteos – peptidomimetics experts
- BioThema – luminescent assays
- NVH Medicinal – new generation of collagen-based products
To receive weekly notifications about the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech companies are listed according geographical points of view (continent / country). If you want to propose a Biotech company to be added to this list, please feel free to contact us !
Lots of very interesting and promising Biotech Companies emerge everyday around the world. Looking for new partners? Biotech365 will present you lots of Biotech companies from all around the world! List of Biotech Companies : every day Biotech-365.com brings you information about the best Biotech Companies ! List Biotech Companies – List Biotech Company. You want to propose a Biotech Company to be presented on this website ? Please use our Contact page !
Biotech 365 is an independent website, sharing information and news about Biotech Companies and Biotechnology. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Biotech Companies – Biotechnology Companies – Biotech Company – Biotechnology Company
Biotech Companies – Biotechnology Companies – Biotech Company – Biotechnology Company
List of Biotech Companies presented on this page : Biotech Companies – Biotechnology Companies – Biotech Company – Biotechnology Company . Biotech 365 brings you every day the more interesting information about Biotech Investors, BiotechCompanies, Biopharma companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates !
BiotechCompanies – Biotechnology Companies – Biotech Company – Biotechnology Company –
If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! If you want to propose a Biotech company to be added to this list, please feel free to contact us ! To receive weekly notifications about the last articles added to Biotech 365, please register to our Newsletter.